A Deep Dive Into The Game-Changing Femtech Revolutionising Women’s Health

For years, female physiology was neglected in medical research – considered “too complex, cyclical or inconvenient”. Now? It ...

ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive ...

AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) in combination with pertuzumab has been approved in the US for the 1st-line treatment of adult patients with unresectable or ...
The Scientist

Endometrial Organoids Open a Window into the Womb

Linda Griffith engineers human uterine endometrium in lab dishes, offering in vitro tools to study some uterine diseases and ...